Efficacy of Intraperitoneal Versus Intravenous Lidocaine for Postcesarean Pain Relief

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Postcesarean Pain Relief
Interventions
DRUG

Intravenous normal saline

Normal saline in a volume equivalent to that used in intravenous lidocaine group

DRUG

Intraperitoneal normal saline

Patients received 00 ml of saline intraperitoneally

DRUG

Intraperitoneal Lidocaine

Patients received 1.75 ml/kg of 0.2% lidocaine (3.5mg/kg) with parietal peritoneal closure.

DRUG

Intravenous Lidocaine

Patients received 1.5mg/kg of intravenous 1% lidocaine as bolus dose at induction and 2mg/kg/hour as continuous infusion of intravenous lidocaine until one hour after surgery.

All Listed Sponsors
lead

Benha University

OTHER

NCT02707081 - Efficacy of Intraperitoneal Versus Intravenous Lidocaine for Postcesarean Pain Relief | Biotech Hunter | Biotech Hunter